ReviewPlastic and reconstructive surgery. Global open2020
Treatment of Non-melanoma Skin Cancers in the Absence of Mohs Micrographic Surgery.
Review in Plastic and reconstructive surgery. Global open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 32 citations in OpenAlex.
- Tailored contact brachytherapy for challenging facial basal cell carcinomas: clinical results of 3D printing technology implementation.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2026Article
- The SLICE-3D dataset: 400,000 skin lesion image crops extracted from 3D TBP for skin cancer detection.Scientific data · 2024Article
- Natural Compounds in Non-Melanoma Skin Cancer: Prevention and Treatment.Molecules (Basel, Switzerland) · 2024Review
- Advancements in skin cancer treatment: focus on photodynamic therapy: a review.American journal of cancer research · 2024Review
- Deep excision surgery of face due to cruel invasion of basal cell carcinoma: A case report study.International journal of surgery case reports · 2023Article
- Nanomaterials for Skin Cancer Photoimmunotherapy.Biomedicines · 2023Review
- The efficacy of dermoscopy in defining the surgical margins of cutaneous squamous cell carcinoma: a retrospective study.Frontiers in oncology · 2023Article
- Basal Cell Carcinoma: A Narrative Review on Contemporary Diagnosis and Management.Oncology and therapy · 2022Review
- Non-melanoma skin cancers: physio-pathology and role of lipid delivery systems in new chemotherapeutic treatments.Neoplasia (New York, N.Y.) · 2022Review
- Overview of Biologic Agents Used in Skin and Soft Tissue Reconstruction.Seminars in plastic surgery · 2022Review
- Use of Biologic Agents in Extremity Reconstruction.Seminars in plastic surgery · 2022Review
- The Use of Biologic Wound Agents in Pediatric Reconstructions.Seminars in plastic surgery · 2022Review
- Use of Biologic Agents for Lip and Cheek Reconstruction.Seminars in plastic surgery · 2022Review
- The Impact of and Adaptations Due to the COVID-19 Pandemic on the Histopathological Diagnosis of Skin Pathologies, Including Non-Melanocyte and Melanoma Skin Cancers-A Single-Center Study in Romania.Medicina (Kaunas, Lithuania) · 2021Article
- Argon-Helium Cryoablation for Cutaneous Squamous Cell Carcinoma in the Elderly.Frontiers in oncology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Non-melanoma skin cancers are the most common malignancies globally. Although non-melanoma skin cancers exhibit low metastatic potential, they can be locally destructive, necessitating complex excisions and reconstructions. Mohs micrographic surgery is the gold-standard treatment for high-risk non-melanoma skin cancers in patients who are appropriate surgical candidates. Despite its efficacy, Mohs micrographic surgery is not readily available in most geographic regions, necessitating that plastic surgeons be well-versed in alternative treatment modalities for non-melanoma skin cancer. Herein, we will discuss the management of non-melanoma skin cancers in settings where Mohs micrographic surgery is not readily available.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.